Archives
Gefapixant Leads to Modest Improvements in Cough
Modest improvement seen in cough frequency, severity, and specific quality of life, but increase seen in treatment-, taste-related adverse events
Risk for Death, Cardiovascular Death Lower for OSA Patients Using CPAP
Reduction seen in low-density coronary artery plaque volume with CPAP and with use of CPAP and GLP-1-mediated weight loss
EASD: Low-Dose Aspirin Tied to Lower Risk for New Diabetes in Older Adults
Findings show low-dose aspirin also slows the increase in fasting plasma glucose over time among initially healthy older adults
ESC: Cumulative Sedentary Time in Younger Years Tied to Changes in Heart Structure
13-year findings reveal sedentary time from childhood through young adulthood associated with progressive left ventricular remodeling
ESC: Catheter Ablation Aids Symptomatic Atrial Fibrillation, End-Stage Heart Failure
Patient benefits seen for all-cause mortality, implantation of a left ventricular assist device, or urgent heart transplantation
ESC: Semaglutide Beneficial for HFpEF Patients With Obesity
Treatment with semaglutide led to larger reductions in symptoms and physical limitations, greater weight loss
ESC: Treating Iron Deficiency May Not Aid Heart Failure Patients
Study did not meet primary endpoint for composite of death, heart failure hospitalization, and exercise function
ESC: Mavacamten Cuts Need for Septal Reduction Tx with Hypertrophic Cardiomyopathy
Sustained improvements seen in left ventricular outflow tract gradients and symptoms
ESC: Adverse Outcomes Increased With Suboptimal Adherence to Aspirin After MI
Risk increased for recurrent MI, ischemic stroke, or death with suboptimal adherence through eight years after MI
ESC: Bystander Defibrillation Improves Out-of-Hospital Cardiac Arrest Survival
Effect was significant even for EMS response times as short as two to four minutes
